港股创新药板块盘初走高，泰凌医药涨近7%

Group 1 - The Hong Kong innovative drug sector experienced an initial rise, with TaiLing Pharmaceutical increasing by nearly 7% [1] - Stone Pharmaceutical saw a rise of over 4% [1] - Other companies such as BeiGene, Zai Lab (603127), and WuXi Biologics also reported gains [1]